North America RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Molecule Type (Small Interfering RNAs (siRNA) and MicroRNA (miRNA)); Application (Genetic Disorders, Oncology, Neurodegenerative Disorders, Cardiovascular, Respiratory Disorders, Infectious Diseases, Renal Diseases, and Other); Route of Administration (Intradermal Injections, Pulmonary Delivery, Intravenous Injections, Intraperitoneal Injections, and Others); and End User (Diagnostic Laboratories, Research and Academic Laboratories, and Hospitals)
Market Introduction
RNA interference (RNAi) is a vital biological process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. RNAi is an essential research tool in cell culture and living organisms because synthetic dsRNA introduced into cells can induce the suppression of specific genes of interest. RNAi may be used for large-scale screens that orderly shutdown each gene in the cell, which can help to know the components necessary for a particular cellular event such as cell division. The pathway is also used as a practical tool in medicine, biotechnology, and insecticides.
Market Overview and Dynamics
The North AmericaRNAi therapeuticsmarket is expected to reach US$ 598.60 million in 2027 from US$ 302.77 million in 2019. The market is anticipated to grow at a CAGR of 9.0% during 2019–2027.The growth of the market is attributed to some key driving factors such as growing investments in RNAi therapies and rising prevalence of infectious diseases & chronic conditions. However, , high cost of RNAi therapy development is expected to obstruct the growth of the market to a certain extent during the forecast years.
Key Market Segments
In terms of molecule type, the small interfering RNAs (siRNA) segment accounted for the largest share of the North America RNAi therapeuticsmarket in 2019.In terms of route of administration, the pulmonary delivery segment accounted for the largest share of the North America RNAi therapeuticsmarket in 2019.In terms of application, oncology segment accounted for the largest share of the North America RNAi therapeuticsmarket in 2019.In terms of end user, research and academic laboratoriessegment accounted for the largest share of the North America RNAi therapeutics market in 2019
Major Sources and Companies Listed
Several major primary and secondary sources associated with the North America RNAi therapeuticsmarket report are theWorld Health Organization (WHO), National Cancer Institute (NCI),Centers of Disease Control and Prevention (CDC),Asthma and Allergy Foundation of America,American Lung Association,the American Cancer Society (ACS), and others.
Reasons to buy report
- It provides understanding of the North America, RNAi therapeuticsmarket landscape and identifies RNAi therapeuticsmarket segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America RNAi therapeuticsmarket.
- It helps efficiently plan merger and acquisition, and partnership deals in the RNAi therapeuticsmarket by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis ofRNAi therapeuticsmarket performance of various segments pertaining to the North America RNAi therapeuticsmarket.
- It providesRNAi therapeuticsmarket revenue forecast of the market based on various segments for the period from 2019 to 2027.
NORTH AMERICA RNAI THERAPEUTICSMARKET SEGMENTATION
By Molecule Type
- Small Interfering RNAs (siRNA)
- MicroRNA (miRNA)
By Route of Administration
- Pulmonary Delivery
- Intravenous Injections
- Intradermal Injections
- Intraperitoneal Injections
- Others
By Application
- Oncology
- Cardiovascular
- Respiratory Disorders
- Renal Diseases
- Genetic Disorders
- Neurodegenerative Disorders
- Infectious Diseases
- Others
By End User
- Research and Academic Laboratories
- Hospitals
- Diagnostic Laboratories
By Country
- US
- Canada
- Mexico
Company Profiles
- Alnylam Pharmaceuticals, Inc
- Arrowhead Pharmaceuticals, Inc
- Quark
- Rexahn Pharmaceuticals, Inc
- Arbutus Biopharma
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America RNAi Therapeutics Market – By Molecule Type
1.3.2 North America RNAi Therapeutics Market – By Application
1.3.3 North America RNAi Therapeutics Market – By Route of Administration
1.3.4 North America RNAi Therapeutics Market– By End User
1.3.5 North America RNAi Therapeutics Market – By Country
2. North America RNAi Therapeutics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America RNAi Therapeutics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 RNAi therapeutics Market - North America PEST Analysis
4.3 Expert Opinion
5. North America RNAi Therapeutics Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Investments in RNAi Therapies
5.1.2 Rising Prevalence of Chronic Conditions and Infectious Diseases
5.2 Market Restraints
5.2.1 High Cost for RNAi Therapy Development
5.3 Market Opportunities
5.3.1 Significant Number of Pipeline Candidates for Strategic Alliances
5.4 Future Trends
5.4.1 Rising Emphasis on RNA Technologies
5.5 Impact analysis
6. RNAi Therapeutics Market – North America Analysis
6.1 North America RNAi Therapeutics Market Revenue Forecasts and Analysis
7. North America RNAi Therapeutics Market Analysis and Forecasts To 2027 – By Molecule Type
7.1 Overview
7.2 North America RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)
7.2.1 North America RNAi therapeutics Market Revenue and Forecasts to 2027, By Molecule Type (US$ Mn)
7.3 Small Interfering RNAs (siRNA)
7.3.1 Overview
7.3.2 North America Small Interfering RNAs (siRNA) Market Revenue and Forecast to 2027 (US$ Mn)
7.4 MicroRNA (miRNA)
7.4.1 Overview
7.4.2 North America MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America RNAi therapeutics Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 North America RNAi therapeutics Market, By Application 2019 & 2027 (%)
8.2.1 North America RNAi therapeutics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Genetic Disorders
8.3.1 Overview
8.3.2 North America Genetic Disorders Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Oncology
8.4.1 Overview
8.4.2 North America Oncology Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Neurodegenerative Disorders
8.5.1 Overview
8.5.2 North America Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Cardiovascular Disorders
8.6.1 Overview
8.6.2 North America Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Respiratory Disorders
8.7.1 Overview
8.7.2 North America Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Infectious Diseases
8.8.1 Overview
8.8.2 North America Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
8.9 Renal Diseases
8.9.1 Overview
8.9.2 North America Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
8.10 Other Disorders
8.10.1 Overview
8.10.2 North America Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America RNAi therapeutics Market Analysis and Forecasts To 2027 – By Route of Administration
9.1 Overview
9.2 North America RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)
9.2.1 North America RNAi therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)
9.3 Intradermal Injections
9.3.1 Overview
9.3.2 North America Intradermal Injections Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Pulmonary Delivery
9.4.1 Overview
9.4.2 North America Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Intravenous Injections
9.5.1 Overview
9.5.2 North America Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Intraperitoneal Injections
9.6.1 Overview
9.6.2 North America Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Other Route of Administrations
9.7.1 Overview
9.7.2 North America Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)
10. North America RNAi Therapeutics Market Analysis – By End-User
10.1 Overview
10.2 North America RNAi Therapeutics Market, By End-User 2019-2027 (%)
10.2.1 North America RNAi Therapeutics Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
10.3 Diagnostic Laboratories
10.3.1 Overview
10.3.2 North America Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Research and Academic Laboratories
10.4.1 Overview
10.4.2 North America Research and Academic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Hospitals
10.5.1 Overview
10.5.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
11. RNAi therapeutics Market Revenue and Forecasts To 2027 – Geographical Analysis
11.1 North America: RNAi Therapeutics Market
11.1.1 Overview
11.1.2 North America: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)
11.1.4 North America: RNAi Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.5 North America: RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.6 North America: RNAi Therapeutics Market, by End User, 2018–2027 (USD Million)
11.1.7 North America: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)
11.1.8 US: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)
11.1.8.3 US: RNAi Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.8.4 US: RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.8.5 US: RNAi Therapeutics Market, by End User, 2018–2027 (USD Million)
11.1.9 Canada: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)
11.1.9.3 Canada RNAi Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.9.4 Canada: RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.9.5 Canada: RNAi Therapeutics Market, by End User, 2018–2027 (USD Million)
11.1.10 Mexico: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)
11.1.10.3 Mexico: RNAi Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.10.4 Mexico: RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.10.5 Mexico: RNAi Therapeutics Market, by End User, 2018–2027 (USD Million)
12. Impact of COVID-19 Pandemic on North America RNAi therapeutics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. Company Profiles
13.1 Alnylam Pharmaceuticals, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Arrowhead Pharmaceuticals, Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Quark
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Rexahn Pharmaceuticals, Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Arbutus Biopharma
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America RNAi therapeutics Market Revenue and Forecasts To 2027, By Molecule Type (US$ Mn)
Table 2. North America RNAi therapeutics Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America RNAi therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)
Table 4. North America RNAi Therapeutics Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 5. North America RNAi Therapeutics Market, by Molecule Type– Revenue and Forecast to 2027 (USD Million)
Table 6. North America RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 7. North America RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 8. North America RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 9. US RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)
Table 10. US RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. US RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 12. US RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Canada RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Canada RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. Canada RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 16. Canada RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 17. Mexico RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Mexico RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 19. Mexico RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 20. Mexico RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 21. Glossary of Terms, RNAi Therapeutics Market
LIST OF FIGURES
Figure 1. RNAi Therapeutics Market Segmentation
Figure 2. North America RNAi Therapeutics Market Overview
Figure 3. Small Interfering RNAs (siRNA) Molecule Type Segment Held Largest Share of RNAi Therapeutics Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America RNAi Therapeutics Market - Leading Country Markets (US$ Mn)
Figure 6. RNAi Therapeutics Market - North America PEST Analysis
Figure 7. RNAi Therapeutics Market Impact Analysis of Driver and Restraints
Figure 8. North America RNAi Therapeutics Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)
Figure 10. North America Small Interfering RNAs (siRNA) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America RNAi therapeutics Market, By Application 2019 & 2027 (%)
Figure 13. North America Genetic Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Oncology Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)
Figure 22. North America Intradermal Injections Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. North America Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. North America Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. North America Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. North America Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. North America RNAi Therapeutics Market, by End-User 2019 & 2027 (%)
Figure 28. North America Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. North America Research and Academic Laboratories Mark et Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. North America: RNAi Therapeutics Market, by Key Country – Revenue (2019) (USD Million)
Figure 32. North America RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 33. North America: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)
Figure 34. US: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Canada: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Mexico: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in North American Country Markets
The List of Companies - North America RNAi Therapeutics Market
- Alnylam Pharmaceuticals, Inc
- Arrowhead Pharmaceuticals, Inc
- Quark
- Rexahn Pharmaceuticals, Inc
- Arbutus Biopharma
- It provides understanding of the North America, RNAi therapeutics market landscape and identifies RNAi therapeutics market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America RNAi therapeutics market.
- It helps efficiently plan merger and acquisition, and partnership deals in the RNAi therapeutics market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of RNAi therapeutics market performance of various segments pertaining to the North America RNAi therapeutics market.
- It provides RNAi therapeutics market revenue forecast of the market based on various segments for the period from 2019 to 2027.